Red Light Holland Reports First Quarter 2026 Results

Executive Summary

• Red Light Holland Corp. reported financial and operational results for the first quarter ended June 30, 2026 (Q1 2026), showing a decline in revenue and gross profit compared to the prior year period.
• The company announced a strategic shift toward Bitcoin, allocating up to $2 million in Bitcoin-related assets and investing $210K in a Bitcoin ETF in June 2025.
• Significant operational updates include entry into the U.S. retail market via Albertsons (Safeway), the launch of Health Canada-approved functional mushroom gummies, and the appointment of Dr. Robin Carhart-Harris as a Scientific Advisor.

Key Details

• Financial Performance (Q1 2026 vs Q1 2025):
  • Revenues: $1.301M (down from $1.559M in Q1 2025).
  • Gross Profit: $0.447M (down from $0.625M in Q1 2025).
  • Adjusted EBITDA Loss: $0.577M (vs. $0.562M loss in Q1 2025).
  • Total Cash Balance: $11.454M (down from $12.838M as at March 31, 2025).
  • Total Assets: $20.141M (down from $21.221M as at March 31, 2025).
• Cash Flow & Treasury Activities:
  • Higher cash usage in Q1 2026 due to the payoff of a debenture in April for $653K.
  • Purchase of a Bitcoin ETF in June for $210K.
  • Excess cash invested in principle-protected high-interest savings vehicles.
• Strategic Bitcoin Initiative:
  • Announced a Bitcoin strategy allocating up to $2 million in Bitcoin-related assets.
  • Led by Cryptocurrency Advisor Scott Melker.
  • Motivated by institutional debanking issues in Canada and a desire for financial infrastructure flexibility.
• Operational & Commercial Updates:
  • U.S. Retail Entry: Entered the U.S. retail market via Albertsons (under the Safeway banner) with Happy Caps Mushroom Home Grow Kits.
  • Product Launch: Launched Health Canada-approved Functional Mushroom Gummies (NPN #80137179) on Amazon.
  • Pilot Program: Launched a pilot for FUNctional mushroom gummies at London, ON Real Canadian Superstore (RCSS); further expansion within RCSS is indicated as likely.
  • SR Wholesale: Remained cash-positive in Q1 2026 with steady sales growth from iMicrodose and Maka truffles in Dutch SmartShops.
• Research & Development:
  • Irvine Labs Partnership: Completed initial potency testing in August 2025 confirming psilocybin truffles are compatible with manufacturing processes for potential medical-grade applications.
  • ASU Partnership: Collaboration with Arizona State University on the Psychedelic Genome Project led by Dr. Candace Lewis to understand genetic factors influencing psilocybin response.
  • Scientific Advisory: Dr. Robin Carhart-Harris joined as Scientific Advisor to guide R&D, policy strategy, and regulatory pathways.
• M&A Activity:
  • Presented a non-binding offer to a potential acquisition target; ongoing discussions are underway.
  • Focus is on acquiring growing CPG companies with strong brand recognition and accretive revenue potential.
• Asset Management:
  • AEM New Brunswick: Recorded rebounded sales in Q1 2026.
  • AEM Ontario (Peterborough): In discussions with an interested party to sell the land and building to consolidate capital.

Notable Quotes

• "Higher use of cash in Q1 2026 as the Company paid off a debenture in April for $653K and purchased Bitcoin ETF in June for $210K"
• "After experiencing institutional debanking in Canada, the Company is exploring Bitcoin as a financial infrastructure alternative for operational flexibility."
• "Red Light Holland remains optimistic about the future. With a diversified foundation including a recently announced Bitcoin balance sheet strategy, bold innovation in psilocybin research, proven business models and constant revaluations with a continued focus on fiscal responsibility... we believe we are well-positioned to lead the next wave of responsible growth in both the psychedelic and functional mushroom sectors."